361 Preclinical activity of AZD0530, a novel, oral, potent and selective inhibitor of the Src family kinases
T.P. Green, M. Fennell, R. Whittaker, J. Curwen, V. Jacobs, J. Allen, P.A. Ple, L.F. Hennequin, G. CostelloVolume:
2
Year:
2004
Language:
english
DOI:
10.1016/s1359-6349(04)80368-9
File:
PDF, 145 KB
english, 2004